Epigenetic Regulation of Immune Dysfunction in Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)

Key Points

• Chronic prostatitis/chronic pelvic pain syndrome shows impaired il-10-mediated immune regulation, indicating significant immune dysfunction.
• Inhibition of dna methylation restored il-10 responses, demonstrating a notable therapeutic potential with a promising outcome.
• Assessment using pharmacologic interventions highlighted the role of demethylation therapy in alleviating pain effectively.
• Results suggest that targeting epigenetic pathways may lead to novel treatments for chronic pelvic pain syndromes.